The FDA’s real-time clinical trials initiative depends on getting trusted site data into reviewable form faster. This session explores how AI-native EDC can revive the original “write once, copy forward” model of clinical research: sites document once, AI maps source data into CRFs, and every field retains traceability back to source. Attendees will learn practical approaches to reduce duplicate entry, accelerate review, preserve ALCOA+ controls, and make real-time trial operations credible for sites, sponsors, and regulators.